FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

409400001: Cetuximab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2004. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2464851018 Cetuximab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2471186019 Cetuximab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2464851018 Cetuximab (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2464851018 Cetuximab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2471186019 Cetuximab en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2471186019 Cetuximab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
945691000195111 cetuximab it Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
499501000274112 Cetuximab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
799601000172112 cétuximab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
799601000172112 cétuximab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
945691000195111 cetuximab it Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
499501000274112 Cetuximab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cetuximab (substance) Is a Epidermal growth factor receptor antagonist true Inferred relationship Existential restriction modifier (core metadata concept)
Cetuximab (substance) Is a anticorps monoclonal chimérique souris-humain d'isotype IgG false Inferred relationship Existential restriction modifier (core metadata concept)
Cetuximab (substance) Is a produit chimique catégorisé selon sa fonction false Inferred relationship Existential restriction modifier (core metadata concept)
Cetuximab (substance) Has disposition Epidermal growth factor receptor inhibitor true Inferred relationship Existential restriction modifier (core metadata concept)
Cetuximab (substance) Has disposition Murine-human monoclonal immunoglobulin G antibody false Inferred relationship Existential restriction modifier (core metadata concept)
Cetuximab (substance) Is a Monoclonal antibody true Inferred relationship Existential restriction modifier (core metadata concept)
Cetuximab (substance) Has disposition Immunomodulator (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Cetuximab (substance) Is a Substance with murine-human monoclonal immunoglobulin G antibody mechanism of action false Inferred relationship Existential restriction modifier (core metadata concept)
Cetuximab (substance) Is a Immunomodulator true Inferred relationship Existential restriction modifier (core metadata concept)
Cetuximab (substance) Is a Enzyme inhibitor protein true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing cetuximab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cetuximab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Cetuximab 2mg/mL injection solution 50mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cetuximab (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing only cetuximab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cetuximab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
allergie au cetuximab Causative agent (attribute) False Cetuximab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Cetuximab 2 mg/mL solution for injection Has precise active ingredient True Cetuximab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Cetuximab 2 mg/mL solution for injection Has basis of strength substance (attribute) True Cetuximab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Cetuximab-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cetuximab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only cetuximab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cetuximab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely cetuximab 5 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Cetuximab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely cetuximab 5 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Cetuximab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Cetuximab 5 mg/mL solution for infusion Has precise active ingredient True Cetuximab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Cetuximab 5 mg/mL solution for infusion Has basis of strength substance (attribute) True Cetuximab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Cetuximab 5 mg/mL solution for infusion and/or injection Has precise active ingredient True Cetuximab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Cetuximab 5 mg/mL solution for infusion and/or injection Has basis of strength substance (attribute) True Cetuximab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Allergy to cetuximab due to alpha-gal syndrome Causative agent (attribute) True Cetuximab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start